📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

BRAWNPharmaceuticals

Brawn Biotech Ltd — Financial Ratios & Key Metrics

₹20.85

-0.71%

P/E RatioN/AxIndustry: 31.77x

ROE-41.33%Return on equity

ROCE-42.52%Return on capital

Debt/Equity0.00Debt free ✓

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹5.78 (Cr)

Sales Growth 5Y

-22.97%

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

-6.41%

📉

Price Returns

1 Month

-8.72%

3 Months

-17.16%

6 Months

+17.08%

1 Year

-6.50%

52W Low

₹16

Current

₹21

52W High

₹24

59% of 52-week range — Mid range

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹21

▲ Price above SMA 50 — Bullish

SMA 200

₹20

▲ Long-term uptrend

Volume Signal

17% of avg

Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

More on Brawn Biotech Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.